Petros Pharmaceuticals, Inc.
PTPI
$0.0849
-$0.007-7.62%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -235.45% | 69.39% | -779.67% | 106.99% | -78.64% |
| Total Depreciation and Amortization | 1.80% | 0.16% | -19.39% | 8.66% | 0.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 90.31% | 0.38% | 71.80% | -466.43% | 62,243.48% |
| Change in Net Operating Assets | 395.66% | -115.88% | 0.85% | 197.24% | -260.91% |
| Cash from Operations | 53.61% | -46.49% | 49.79% | 44.15% | -607.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.50% | -- | -- | -1.52% | -1.49% |
| Issuance of Common Stock | -- | -- | -- | 0.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -51.38% | -40.76% | 43.90% | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -41.70% | -74.63% | 52.75% | -116.22% | 4,128.47% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.53% | -60.47% | 51.30% | -143.77% | 1,231.74% |
